5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.38▼ | 0.38▼ | 0.38▼ | 0.39▼ | 0.39▼ |
MA10 | 0.38▼ | 0.39▼ | 0.39▼ | 0.39▼ | 0.41▼ |
MA20 | 0.39▼ | 0.39▼ | 0.39▼ | 0.39▼ | 0.39▼ |
MA50 | 0.39▼ | 0.39▼ | 0.39▼ | 0.43▼ | 0.98▼ |
MA100 | 0.39▼ | 0.39▼ | 0.40▼ | 0.39▼ | 1.56▼ |
MA200 | 0.39▼ | 0.42▼ | 0.42▼ | 0.86▼ | 5.12▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | -0.001▼ | -0.001▼ | -0.001▼ | 0.046▲ |
RSI | 41.246▼ | 44.156▼ | 44.607▼ | 44.161▼ | 38.619▼ |
STOCH | 24.462 | 24.194 | 20.270 | 37.773 | 29.363 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -70.102 | -60.825 |
CCI | -85.707 | -110.785▼ | -122.009▼ | -71.984 | -28.948 |
▲ GAP | $BCAB Open Gap Up %2 | Set Alert |
Sunday, May 18, 2025 05:00 PM
Dimensional Fund Advisors LP trimmed its position in shares of BioAtla, Inc. (NASDAQ:BCAB – Free Report) by 49.2% in the 4th quarter, according to the company in its most recent disclosure with ...
|
Tuesday, May 06, 2025 08:21 PM
BioAtla Inc (NASDAQ:BCAB) has managed to reduce their R&D expenses significantly, which is expected to provide sufficient runway to fund operations and achieve key clinical readouts in the first ...
|
Tuesday, May 06, 2025 01:06 PM
SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 0.38 | 0.392 | 0.38 | 0.3835 | 675,652 |
10/07/25 | 0.3977 | 0.3999 | 0.3802 | 0.3866 | 631,763 |
09/07/25 | 0.39 | 0.4163 | 0.385 | 0.3878 | 890,641 |
08/07/25 | 0.3866 | 0.40 | 0.3842 | 0.3881 | 493,263 |
07/07/25 | 0.376 | 0.40 | 0.3759 | 0.386 | 516,918 |
03/07/25 | 0.38 | 0.3935 | 0.36 | 0.3761 | 1,326,584 |
02/07/25 | 0.3922 | 0.4093 | 0.3899 | 0.3977 | 353,131 |
01/07/25 | 0.39 | 0.4088 | 0.39 | 0.3905 | 177,627 |
30/06/25 | 0.38 | 0.3999 | 0.38 | 0.396 | 141,043 |
27/06/25 | 0.39 | 0.3975 | 0.372 | 0.384 | 389,590 |
|
|
||||
|
|
||||
|
|